Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Ny era för läkemedelsstudier

- Det här kräver en total omställning, säger Jan Trøst Jørgensen som forskar inom personalized medicne.

LEO Pharma - International Clinical Trial Manager

High hopes for future partnering - the solution for struggling fairs

Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.